Adaptimmune Therapeutics Stock (NASDAQ:ADAP), Quotes and News Summary

Q: What sector and industry does Adaptimmune Therapeutics (ADAP) operate in?

Adaptimmune Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Adaptimmune Therapeutics Stock (NASDAQ: ADAP) stock price, news, charts, stock research, profile.

Open	$0.920
Close	$0.977
Volume / Avg.	1.482M / 1.966M
Day Range	0.920 - 1.100
52 Wk Range	0.420 - 2.050
Market Cap	$250.451M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	33
Short Interest	1.88%
Days to Cover	2.27

Recent News

Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial results and issued weak Q1 guidance.

Avi Kapoor

Smith & Wesson Brands Reports Upbeat Earnings, Joins America's Car-Mart, HCI Group And Other Big Stocks Moving Higher On Friday

U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Friday.

Avi Kapoor

Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

1.8

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

About Adaptimmune Therapeutics Plc

Sector

Health Care

Industry

Biotechnology

Adaptimmune Therapeutics PLC is a clinical-stage biopharmaceutical company. It focused on providing ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Adaptimmune Therapeutics (ADAP) stock?

You can purchase shares of Adaptimmune Therapeutics (NASDAQ: ADAP) through any online brokerage.

View our list of the best stock brokerages.

Who are Adaptimmune Therapeutics's (ADAP) competitors?

Other companies in Adaptimmune Therapeutics’s space includes: Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), Inovio Pharmaceuticals (NASDAQ:INO), Abeona Therapeutics (NASDAQ:ABEO) and Design Therapeutics (NASDAQ:DSGN).

What is the target price for Adaptimmune Therapeutics (ADAP) stock?

The latest price target for Adaptimmune Therapeutics (NASDAQ: ADAP) was reported by Barclays on Thursday, August 10, 2023. The analyst firm set a price target for 1.00 expecting ADAP to rise to within 12 months (a possible 2.04% upside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for Adaptimmune Therapeutics (ADAP)?

The stock price for Adaptimmune Therapeutics (NASDAQ: ADAP) is $0.98 last updated April 19, 2024 at 6:33 PM EDT.

Does Adaptimmune Therapeutics (ADAP) pay a dividend?

There are no upcoming dividends for Adaptimmune Therapeutics.

When is Adaptimmune Therapeutics (NASDAQ:ADAP) reporting earnings?

Adaptimmune Therapeutics’s Q1 earnings are confirmed for Friday, May 10, 2024.

Is Adaptimmune Therapeutics (ADAP) going to split?

There is no upcoming split for Adaptimmune Therapeutics.

What sector and industry does Adaptimmune Therapeutics (ADAP) operate in?

Adaptimmune Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-